B

BenevolentAI
BAI

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
-
EV
-
Shares Outstanding
-
Beta
-

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€2.02
P/E 2024E
-
P/Revenue 2024E
1.07x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BenevolentAI S.A.

gainify

B

BenevolentAI S.A.

BAI

BenevolentAI S.A. operates as a clinical-stage artificial intelligence (AI) enabled drug discovery and development company. Its Benevolent platform integrates AI and science to uncover and develop drugs for complex diseases. The company’s development pipeline includes...

Sector

Healthcare

Industry

Biotechnology

CEO

Data Unavailable

Employees

IPO Date

2022-04-25

Headquarters

4-8 Maple Street, London, Greater London, W1T 5HD, United Kingdom

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved